61352 Bad Homburg, de
+49 (6172) 608-2872
Sales and net income reach all-time highs
6% dividend increase proposed / Positive Group outlook for 2015
22nd consecutive dividend increase proposed
Based on the strong financial results, the Management Board will propose to the Supervisory Board a dividend increase of 6% to €0.44 per share (2013: €1.25 pre 1:3 share split). The total dividend distribution is expected to be €238 million.
Positive Group outlook for 2015
For 2015, Fresenius projects sales growth of 7% to 10% in constant currency. Net income1 is expected to increase by 9% to 12% in constant currency.
The net debt/EBITDA2 ratio is expected to be at approximately 3.0 at the end of 2015.
16% constant currency sales growth - at top end of guidance
Group sales increased by 14% (16% in constant currency) to €23,231 million (2013: €20,331 million). Organic sales growth was 4%. Currency translation had a negative effect of 2%. Acquisitions contributed 12%. Divestitures had a marginal effect on sales growth.
In Q4/2014, Group sales increased by 23% (20% in constant currency) to €6,520 Million (Q4/2013: €5,299 million). Organic sales growth was 6%.
1 Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015 before integration costs (~€10 million before tax for hospitals acquired from Rhön-Klinikum AG), before costs for the efficiency program at Fresenius Kabi (~€100 million before tax), and before the gain from the divestment of two HELIOS hospitals (€34 million before tax); 2014 before special items
2 At annual average exchange rates for both net debt and EBITDA; without major acquisitions; before special items
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an firstname.lastname@example.org.